IRIS

Silver

CASRN 7440-22-4 | DTXSID4024305

Noncancer Assessment

Reference Dose for Oral Exposure (RfD) (PDF) (14 pp, 120 K) Last Updated: 12/01/1991

System RfD (mg/kg-day) Basis PoD Composite UF Confidence
Dermal 5 x 10 -3 Argyria LOAEL : 1.4 x 10-2
mg/kg-day
3 Low

 


Reference Concentration for Inhalation Exposure (RfC) (PDF) (14 pp, 120 K)
Not assessed under the IRIS Program.

 

Cancer Assessment

Weight of Evidence for Cancer (PDF) (14 pp, 120 K) Last Updated: 06/01/1989

WOE Characterization Framework for WOE Characterization
D (Not classifiable as to human carcinogenicity) Guidelines for Carcinogen Risk Assessment (U.S. EPA, 1986)
Basis:
  • In animals, local sarcomas have been induced after implantation of foils and discs of silver. However, the interpretation of these findings has been questioned due to the phenomenon of solid-state carcinogenesis in which even insoluble solids such as plastic have been shown to result in local fibrosarcomas.
  • This may be a synopsis of the full weight-of-evidence narrative.

Quantitative Estimate of Carcinogenic Risk from Oral Exposure (PDF) (14 pp, 120 K)

Not assessed under the IRIS Program.

Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure (PDF) (14 pp, 120 K)

Not assessed under the IRIS Program.


Additional EPA toxicity information may be available by visiting the following sites:

You will need Adobe Reader to view some of the files on this page. See EPA's PDF page to learn more.

Contact Us to ask a question, provide feedback or report a problem.